Latest preclinical study suggests broader potential utility of MDM2 antisense

MLA

“Latest Preclinical Study Suggests Broader Potential Utility of MDM2 Antisense.” Biotech Week, 24 Mar. 2004, p. 223. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.114414169&authtype=sso&custid=ns315887.

APA

Latest preclinical study suggests broader potential utility of MDM2 antisense. (2004, March 24). Biotech Week, 223.

Chicago

Biotech Week. 2004. “Latest Preclinical Study Suggests Broader Potential Utility of MDM2 Antisense,” March 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.114414169&authtype=sso&custid=ns315887.